Will the markers of gastric cancer tumors increase?

Normally, if a patient has gastric cancer and is in the early stages of the disease, they may have elevated tumor markers. However, as the disease progresses and treatment progresses, the patient's tumor marker levels may gradually decrease.

Gastric cancer is a malignant tumor that is relatively common in clinical practice. In the early stages of the disease, since tumor cells are relatively small and few in number, they do not cause significant damage or destruction to surrounding tissues. At this time, the body's immune system can effectively identify and eliminate these abnormal cells. In this case, tumor markers generally do not increase significantly or fluctuate within the normal range.

However, over time, tumor cells begin to proliferate and spread to surrounding tissues. This can lead to inflammatory responses and other pathological changes, which can cause more tumor markers to be produced in the body. When tumor cells are attacked by other mechanisms of the body's immune system, some chemicals are also released to stimulate the body to produce corresponding antibodies. These factors can all lead to increased tumor marker levels.

It is worth noting that although tumor markers can help doctors assess the presence and progression of cancer, they are not a reliable diagnostic method. For people who are suspected of having gastric cancer or other malignant tumors, further examinations should be performed to confirm the diagnosis. For example, more accurate information can be obtained through endoscopy, imaging scans, etc.

Whether the tumor marker will rise after gastric cancer depends on the specific situation. In the early stage, it may remain stable or even decrease; but in the late stage, it often increases significantly. Early detection and treatment are crucial. If you have any questions, please consult a professional doctor.